Raymond James Financial Services Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,428
| Closed | -$39K | – | 2913 |
|
|
2018
Q3 | $39K | Sell |
11,428
-3,367
| -23% | -$11.5K | ﹤0.01% | 2717 |
|
|
2018
Q2 | $56K | Sell |
14,795
-1,990
| -12% | -$7.53K | ﹤0.01% | 2657 |
|
|
2018
Q1 | $69K | Buy |
16,785
+200
| +1% | +$822 | ﹤0.01% | 2415 |
|
|
2017
Q4 | $77K | Sell |
16,585
-940
| -5% | -$4.36K | ﹤0.01% | 2392 |
|
|
2017
Q3 | $124K | Buy |
17,525
+1,030
| +6% | +$7.29K | ﹤0.01% | 2362 |
|
|
2017
Q2 | $119K | Buy |
16,495
+5,628
| +52% | +$40.6K | ﹤0.01% | 2317 |
|
|
2017
Q1 | $67K | Buy |
+10,867
| New | +$67K | ﹤0.01% | 2283 |
|